rTMS for the Treatment of Freezing of Gait in Parkinson's Disease
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Freezing of Gait in Parkinson's Disease
1 other identifier
interventional
30
1 country
1
Brief Summary
This study is a double blind comparative study examining the effectiveness of the rTMS treatment on Freezing of Gait (FOG) in patients with Parkinson's disease (PD). The investigators hypothesize that treatment with rTMS on supplemental motor area will improve gait quality and decrease the frequency of FOG in PD patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 3, 2017
CompletedFirst Posted
Study publicly available on registry
July 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedResults Posted
Study results publicly available
May 14, 2021
CompletedMay 14, 2021
April 1, 2021
3 years
July 3, 2017
June 28, 2020
April 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of the New Freezing of Gait Questionnaire (NFOGQ) Score
NFOGQ ranges from 0-24 points. It is used to quantify changes of the FOG frequency and severity. Higher scores mean a worse outcome.
Pre-treatment, post-treatment 4 weeks
Secondary Outcomes (4)
Motor Subscale of the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS Part III)
Pre-treatment, post-treatment 4 weeks
Cadence
Pre-treatment, post-treatment 4 weeks
Turning Duration
Pre-treatment, post-treatment 4 weeks
Changes of Brain Functional Connectivity.
Pre-treatment, post-treatment at 2 weeks
Study Arms (2)
High-frequency rTMS
EXPERIMENTALPatients randomized to this group will receive rTMS delivering over the supplementary motor area (SMA). Each treatment consists 1000 pulses (5-second burst of 10Hz rTMS, repeated 20 times at every minute ).Stimulus intensity is 90% of resting motor threshold. A figure-of-8 coil is connected to a biphasic magnetic stimulator, and the induced current is perpendicular to the midline.
Sham rTMS
SHAM COMPARATORPatients randomized to this group will receive the sham rTMS. The procedure is same as used in patients receiving experimental rTMS, except that the coil is angled 90° away.
Interventions
It is delivered at a 5-second burst of 10Hz stimuli, repeated 20 times at every minute. Each treatment contains a total of 1000 pulses. Stimulus intensity is 90% of resting motor threshold. The SMA stimulation will be given using a coil centered at points 3-cm anterior to the leg motor area in the sagittal midline.
The procedure will be same as the high-frequency rTMS except that the coil is 90° angled away.
Eligibility Criteria
You may qualify if:
- Idiopathic PD patients.
- Presenting with FOG.
- The mini-mental state examination questionnaire score above 24 points.
You may not qualify if:
- Other neurological or psychiatric disorders.
- History of epilepsy, seizures or convulsions.
- Metal implantation.
- History of exposure to rTMS in the past (to minimizing risk of unblinding sham condition).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xuanwu Hospital
Beijing, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Piu Chan
- Organization
- Xuanwu Hospital
Study Officials
- STUDY DIRECTOR
Piu Chan, MD, PhD
Xuanwu Hospital, Beijing
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
July 3, 2017
First Posted
July 18, 2017
Study Start
December 1, 2016
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
May 14, 2021
Results First Posted
May 14, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share